These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14201140)

  • 41. Effect of phosphorylated cyclocytidine on deoxyribonucleic acid polymerase.
    Hoshi A; Kanzawa F; Kuretani K; Kanai T; Ichino M
    Biochem Pharmacol; 1973 Nov; 22(22):2829-34. PubMed ID: 4761553
    [No Abstract]   [Full Text] [Related]  

  • 42. SYNTHESIS OF POSSIBLE CANCER CHEMOTHERAPEUTIC COMPOUNDS BASED ON ENZYME APPROACH. IV. AZIRIDINE DERIVATIVES.
    TSOU KC; HOEGERLE K; SU HC
    J Med Chem; 1963 Jul; 6():435-9. PubMed ID: 14184901
    [No Abstract]   [Full Text] [Related]  

  • 43. TUMOR AND VIRUS ANTIGENS OF SIMIAN VIRUS 40: DIFFERENTIAL INHIBITION OF SYNTHESIS BY CYTOSINE ARABINOSIDE.
    RAPP F; MELNICK JL; KITAHARA T
    Science; 1965 Feb; 147(3658):625-7. PubMed ID: 14241415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EFFECT OF DRUGS ON CELL AND VIRUS GROWTH IN FRIEND LEUKEMIA AND A TUMOR VARIANT.
    DAWSON PJ; FIELDSTEEL AH; BOSTICK WL
    Proc Soc Exp Biol Med; 1965 May; 119():206-8. PubMed ID: 14297847
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
    Mizuno NS; Humphrey EW
    Cancer Chemother Rep; 1969 Sep; 53(4):215-21. PubMed ID: 5384462
    [No Abstract]   [Full Text] [Related]  

  • 46. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1985 Aug; 45(8):3642-5. PubMed ID: 3926306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PRODUCTION AND THE MECHANISM OF ACTION OF OLIVOMYCIN, AN ANTITUMOUR ANTIBIOTIC.
    GAUSE GF; UCHOLINA RS; SVESHNIKOVA MA
    Acta Unio Int Contra Cancrum; 1964; 20():284-5. PubMed ID: 14151908
    [No Abstract]   [Full Text] [Related]  

  • 48. THE SYNTHESIS AND ANTINEOPLASTIC PROPERTIES OF SELENOGUANINE, SELENOCYTOSINE AND RELATED COMPOUNDS.
    MAUTNER HG; CHU SH; JAFFE JJ; SARTORELLI AC
    J Med Chem; 1963 Jan; 6():36-9. PubMed ID: 14174027
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.
    Ho DH; Frei E
    Clin Pharmacol Ther; 1971; 12(6):944-54. PubMed ID: 5289712
    [No Abstract]   [Full Text] [Related]  

  • 50. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract]   [Full Text] [Related]  

  • 51. Combination therapy with mitomycin C,5-fluorouracil, and cytosine arabinoside in P815 ascites and solid mouse neoplasms.
    Kreis W
    Cancer Treat Rep; 1976 Sep; 60(9):1399-1400. PubMed ID: 1016974
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of deficiencies in DNA repair on the toxicity of mitomycin C and porfiromycin to CHO cells under aerobic and hypoxic conditions.
    Hughes CS; Irvin CG; Rockwell S
    Cancer Commun; 1991 Feb; 3(2):29-35. PubMed ID: 1899798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
    Avery TL; Roberts D
    Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
    [No Abstract]   [Full Text] [Related]  

  • 54. QUANTITATIVE CONCEPTS IN THE CLINICAL STUDY OF DRUGS.
    ZUBROD CG
    Adv Chemother; 1964; 12():9-34. PubMed ID: 14198208
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect and toxicity of combination treatment including cyclocytidine or cytosine arabinoside in L-1210 and sarcoma-180 systems.
    Hoshi A; Kanzawa F; Iigo M; Kuretani K
    Gan; 1975 Oct; 66(5):539-46. PubMed ID: 1220992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HYDROXYUREA. A NEW TYPE OF POTENTIAL ANTITUMOR AGENT.
    STEARNS B; LOSEE KA; BERNSTEIN J
    J Med Chem; 1963 Mar; 6():201. PubMed ID: 14188794
    [No Abstract]   [Full Text] [Related]  

  • 57. INHIBITORY EFFECT OF ANTI-CANCER CHEMOTHERAPEUTICS ON LIVER METASTASIS OF INTRAPORTALLY INOCULATED MOUSE ASCITES HEPATOMA.
    KOIZUMI A; YOSHIDA K; TAKAHASHI T; YAMAGUCHI I; MAJIMA S
    Tohoku J Exp Med; 1964 Apr; 82():250-9. PubMed ID: 14166835
    [No Abstract]   [Full Text] [Related]  

  • 58. Differential cytotoxicity of cytosine arabinoside toward murine leukemia L1210 cells and murine bone marrow progenitor cells inhibited in nucleoside transport by cimicifugoside.
    Hemmi H
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):565-8. PubMed ID: 6791252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nucleic acids. II. Cytotoxicity studies with nucleotides and dinucleoside phosphates containing ara-cytidine.
    Smith CG; Buskirk HH; Lummis WL
    J Med Chem; 1967 Sep; 10(5):774-6. PubMed ID: 6048482
    [No Abstract]   [Full Text] [Related]  

  • 60. POTENTIATION OF THE ANTI-LEUKEMIC EFFECTS OF 2-AMINOTHIADIAZOLE BY ISONICOTINAMIDE AND DERIVATIVES.
    OETTGEN HF; PURPLE JR; COLEY VC; KRAKOFF IH; BURCHENAL JH
    Cancer Res; 1964 May; 24():689-92. PubMed ID: 14188475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.